These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3787198)

  • 21. Endoscopic Neodymium-YAG laser application for destroying bladder tumors.
    Hofstetter A; Frank F; Keiditsch E; Böwering R
    Eur Urol; 1981; 7(5):278-82. PubMed ID: 6894732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The microcirculation in neodymium-YAG laser irradiated and in electrocoagulated urinary bladder tumors evaluated with laser Doppler flowmetry.
    Beisland HO; Kvernebo K
    Urol Res; 1986; 14(3):149-52. PubMed ID: 2944269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
    Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
    Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flexible cystoscopy and Holmium:Yttrium aluminum garnet laser ablation for recurrent nonmuscle invasive bladder carcinoma under local anesthesia.
    Syed HA; Talbot N; Abbas A; MacDonald D; Jones R; Marr TJ; Rukin NJ
    J Endourol; 2013 Jul; 27(7):886-91. PubMed ID: 23537221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
    Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
    Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of Nd:YAG laser and flexible cystoscope in outpatient treatment of recurrent superficial bladder tumors].
    Ishikawa S; Sasaki A; Tsuruta A; Hinotsu S; Koiso K
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):707-10. PubMed ID: 8492515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome.
    Herr HW
    J Clin Oncol; 2001 Jan; 19(1):89-93. PubMed ID: 11134199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nd. Yag treatment of bladder tumors].
    Kardos R; Magasi P; Karsza A
    Orv Hetil; 1994 Feb; 135(8):395-7. PubMed ID: 8139841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
    Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
    Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
    Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The feasibility and safety of cryoablation as an adjuvant therapy with transurethral resection of bladder tumor: A pilot study.
    Liu S; Zhang L; Zou L; Wen H; Ding Q; Jiang H
    Cryobiology; 2016 Oct; 73(2):257-60. PubMed ID: 27393244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience.
    de Crevoisier R; Ammor A; Court B; Wibault P; Chirat E; Fizazi K; Theodore C; Yom SS; Haie-Meder C
    Radiother Oncol; 2004 Aug; 72(2):147-57. PubMed ID: 15376367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological evaluation of superficial bladder tumors treated by Nd-YAG laser and transurethral resection.
    Vicente J; Salvador J; Laguna P; Algaba F
    Eur Urol; 1991; 20(3):192-6. PubMed ID: 1823041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can tumor recurrence be reduced with plasma-kinetic vaporization of the area around the tumor in nonmuscle invasive bladder cancer?
    Yılmaz Y; Kahya MC; Dilek FH; Köse O; Özcan S; Can E; Akın Y; Ergani B; Dindar AS
    Investig Clin Urol; 2018 Jul; 59(4):223-231. PubMed ID: 29984336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser].
    Dmitriev BV; Nikol'skiĭ AD; Latyshev MM; Zolin VP; Sanevich RA
    Urol Nefrol (Mosk); 1997; (1):25-8. PubMed ID: 9123661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
    Flamm J; Kühnel W; Dona S
    Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative doxorubicin instillation in recurrent superficial bladder cancer.
    Kubota Y; Noguchi S; Shuin T; Moriyama M; Hosaka M; Satomi Y; Furuhata A; Kondo I; Sakuramoto T; Yao M
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S56-9. PubMed ID: 3664944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.